EURACTIV - Belgian and European biotech competitiveness will fail unless there's a redesign of how high-risk therapies move from labs to patients, warns a KU Leuven researcher involved in translating high-risk science into early-stage trials. The warning comes as Brussels advances the Biotech Act and a sweeping reform of EU pharmaceutical rules. ...

EU PERSPECTIVES - Sanofi has reaffirmed its commitment to innovating 'from France for the world'. The pharma company announced at the recent Choose France Summit that it is consolidating or launching €1bn in new investments across the country in 2025–2026. Read more

EU PERSPECTIVES - Medicine is approaching a decisive year. In a year-ahead outlook, Nature Medicine asked leading researchers to identify the clinical trials they believe could shape medicine in 2026. Their selections span infectious diseases, cardiovascular care, cancer, autoimmune disorders, rare diseases and neurological repair. Read more

EU PERSPECTIVES - As the European Commission rolls out the latest health package, revised rules for medical devices sit at the centre of the debate. In an interview with EU Perspectives, Jesús Rueda Rodríguez, Director General for Industrial Affairs & Strategies at MedTech Europe, warned Europe risks losing medical innovation and delaying access...

EU PERSPECTIVES - The Commission's proposed Biotech Act marks a shift in how the EU sees its place in the global innovation race. For years, Europe invested heavily in scientific excellence. It left scale, speed and capital formation to national systems and market forces. That model no longer works. Read more

EU PERSPECTIVES - European health systems are changing faster than at any point in the past decade. The debate has shifted. The question is no longer whether reform is needed. It is whether it is happening fast enough, and at sufficient scale. Read more

EU PERSPECTIVES - Last week, the European Parliament's health committee adopted its report on the Critical Medicines Act (CMA). The measure passed with 27 votes in favour, one against and eight abstentions. But while MEP's hail it as a breakthrough, the pharma industry says the plan risks drifting away from its original goal. Read more

EURACTIV - Belgium's federal medicines regulator now treats vaccines as an essential part of the critical national infrastructure, as climate change pushes tropical and vector-borne diseases further north each year. Read more

EURACTIV - Belgium's NEED project is gaining influence in the WHO's innovation strategy, with Belgium's Deputy Prime Minister and Health Minister Frank Vandenbroucke casting it as a foundational tool for steering innovation to where public value is greatest. Read more

EU PERSPECTIVES - The European Commission has unveiled a broad set of health measures. It brings together the Biotech Act, a major overhaul of medical device rules, and the EU's first-ever cardiovascular strategy. The Union's executive arm says the initiative is essential to secure Europe's medical future. Read more